Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows From Operating Activities:
Net income (loss)	$ 168,959	$ (1,466,793)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and Amortization	382,453	564,800
Bad debt expense	$ 43,140	124,982
Charitable non-cash donations		157,950
Stock compensation expense	$ 775,202	$ 1,796,386
Loss on short-term marketable securities	26,128
(Increase) decrease in:
Trade receivables	(1,232,910)	$ (114,988)
Prepaids and other assets	49,387	(419,887)
(Decrease) increase in:
Accounts payable	(170,736)	84,713
Accrued liabilities	(59,270)	26,004
Deferred revenue	219,924	(244,391)
Net cash provided by operating activities	202,277	$ 508,776
Cash Flows From Investing Activities:
Purchase of Marketable Securities	(4,639,036)
Sale of Marketable Securities	$ 4,612,908
Cash advanced on note receivable		$ (1,059,460)
Purchase of property and equipment	$ (31,987)	$ (362,089)
Capitalization of software costs	(109,895)
Purchase of long-term investments	(471,584)
Net cash used in investing activities	(639,594)	$ (1,421,549)
Cash Flows From Financing Activities:
Proceeds from issuance of note payable	396,000	172,795
Proceeds from employee stock plans	199,848	$ 203,211
Proceeds from exercise of warrants	$ 33,002
Proceeds from issuance of stock		$ 903,469
Series B preferred redemption		(7,500)
Dividends paid	$ (7,932)	(154,473)
Payments on notes payable and capital leases	(176,153)	(190,127)
Net cash provided by (used in) financing activities	444,765	927,375
Net increase in cash and cash equivalents	7,448	14,602
Cash and cash equivalents at beginning of period	11,325,572	3,352,559
Cash and cash equivalents at end of period	$ 11,333,020	$ 3,367,161
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes
Cash paid for interest	$ 16,761	$ 55,122
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock to pay accrued liabilities	1,522,281	1,619,962
Preferred stock to pay accrued liabilities	300,000	300,000
Dividends accrued on preferred stock	546,536	444,645
Dividends paid with preferred stock	$ 486,190	291,385
Series B Restructure		$ 2,141,980